Paratek Pharmaceuticals Inc (PRTK.OQ)
PRTK.OQ on NASDAQ Stock Exchange Global Market
11.00USD
20 Apr 2018
11.00USD
20 Apr 2018
Change (% chg)
$-0.22 (-2.00%)
$-0.22 (-2.00%)
Prev Close
$11.23
$11.23
Open
$11.15
$11.15
Day's High
$11.15
$11.15
Day's Low
$10.50
$10.50
Volume
256,774
256,774
Avg. Vol
97,413
97,413
52-wk High
$29.00
$29.00
52-wk Low
$10.50
$10.50
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2017 | Dec '17 | 5.07 | -0.783 |
| Sep '17 | 0.01 | -0.768 | |
| Jun '17 | 7.51 | -0.665 | |
| Mar '17 | 0.02 | -1.144 | |
| FY 2016 | Dec '16 | 0.03 | -1.158 |
| Sep '16 | 0.00 | -1.044 | |
| Jun '16 | 0.00 | -1.692 | |
| Mar '16 | 0.00 | -1.775 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 9 | 0.04 | 0.30 | 0.00 | -- |
| Quarter Ending Sep-18 | 9 | 4.92 | 20.30 | 0.00 | -- |
| Year Ending Dec-18 | 10 | 15.57 | 70.10 | 0.00 | 25.16 |
| Year Ending Dec-19 | 9 | 48.52 | 185.30 | 12.50 | 51.04 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 8 | -0.91 | -0.77 | -1.11 | -- |
| Quarter Ending Sep-18 | 8 | -0.77 | -0.29 | -1.12 | -- |
| Year Ending Dec-18 | 9 | -3.26 | -1.45 | -4.13 | -2.67 |
| Year Ending Dec-19 | 9 | -2.65 | 0.21 | -4.03 | -2.13 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
Dividends
Growth Rates
Financial Strength
Profitability Ratios
Efficiency
Management Effectiveness
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -60.71 | -72.86 |
| EPS (TTM) % | -28.36 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Paratek Pharmaceuticals Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Paratek Pharmaceuticals Prices $140 Mln Of Convertible Senior Subordinated Notes Due 2024
- BRIEF-Paratek Pharmaceuticals Announces Proposed Private Offering Of $125 Mln Of Convertible Senior Subordinated Notes Due 2024
- BRIEF-Paratek Appoints Rolf Hoffman To Co's Board Of Directors
- BRIEF-Paratek's New Drug Applications For Oral And Intravenous Omadacycline Accepted For Priority Review By FDA
- BRIEF-Paratek Pharmaceuticals Reports Q4 Loss Per Share $0.78
Institutional Holders
| % Shares Owned: | 79.39% |
| # of Holders: | 170 |
| Total Shares Held: | 24,961,421 |
| 3 Mo. Net Change: | 46,454 |
| # New Positions: | 3 |
| # Closed Positions: | 2 |
| # Increased Positions: | 13 |
| # Reduced Positions: | 9 |
| # Net Buyers: | 4 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.